Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection

Phase 4WithdrawnNCT02034890

Rabin Medical Center

Overview

Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt to reduce the incidence of urinary tract infections in patients after orthotopic neobladder reconstruction.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Conditions

Urinary Tract Infection

Interventions

Hyaluronic AcidDRUG

intravesical instillation of 40 mg of hyaluronic acid in 6 specific time points: 1,2,3 and 4 weeks postoperatively (After radical cystectomy and orthotopic neobladder reconstruction) 2 and 3 months postoperatively

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients undergoing radical cystectomy and orthotopic neobladder reconstruction Exclusion Criteria: * patients \<18 years and unwilling to participate in this study

Locations (1)

Urology department, Rabin Medical Center

Petach Tiqva, Israel

Outcomes

Primary Outcomes

positive urinary culture

Time frame: 6 months

Secondary Outcomes

urinary tract infection

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.